Artificial Intelligence Eye Screening Software Market Size, Share, Growth, and Industry Analysis, By Type (Diabetic Retinopathy (DR), Age-Related Macular Degeneration (AMD), Myopia & Others), By Application (Medical Institutions & Great Health Scene) and Regional Forecast to 2033

Last Updated: 02 June 2025
SKU ID: 27877082

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

ARTIFICIAL INTELLIGENCE EYE SCREENING SOFTWARE MARKET REPORT OVERVIEW

The global Artificial Intelligence Eye Screening Software Market size stood at USD 0.22 Billion in 2024 and is projected to reach USD 0.41 Billion in 2025, growing further to USD 54.87 Billion by 2033 at an estimated CAGR of 84%.

This Eye Screening Software constitutes heavenly built solution to identify and diagnose eye diseases in the early stages. Thus, relying on digitally taken images of eye, this software is capable of detecting the early symptoms of diseases such as glaucoma, diabetic retinopathy and macular degeneration. Its advanced algorithms are able to analyse images within a controlled time while not requiring constantly time-consuming examinations. Besides, it enhances the speed of eye care work and also enhances access to early diagnosis and treatment hence reducing blindness or poor vision among many.

COVID-19 IMPACT

COVID-19 Impact: Market Growth Restrained due to Importance of Remote Screening Solutions

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

COVID-19 forced doctors and healthcare administrators to push adoption and development of AI eye screening software. When the need for in-person patient talks and appointments reduced to curb the spread of the virus remote screening solutions gained importance. Artificial intelligence enhanced non-contact and contact medical examination related devices for safe eye test that could detect glaucoma and other diseases like diabetic retinopathy at an early stage. COVID19 exposed the need for technology solutions that could facilitate easy access to health care and spurred demand for AI eye screening solutions and growth in the market.

LATEST TRENDS

Telemedicine to Propel the Market Growth

As the use of telemedicine continues to grow, the AI eye screening software integrates with these platforms to offer full remote eye care solutions. These constant advancements in deep learning are showing a marked improvement in the efficiency of the binary classifiers helping detect even early symptoms of the eye diseases. AI is being used in cases of decentralized eye diseases that are difficult to diagnose leading to better patient experience. There are still further attempts being made to develop the AI-based screening devices that are portable and easy on the pocket can be used to screen the eyes of the people staying in the remote or developing countries.

 Artificial Intelligence Eye Screening Software Market

ask for customizationRequest a Free sample to learn more about this report

ARTIFICIAL INTELLIGENCE EYE SCREENING SOFTWARE MARKET SEGMENTATION

By Type

Based on type the market can be categorized into Diabetic Retinopathy (DR), Age-Related Macular Degeneration (AMD), Myopia & Others

  • Diabetic Retinopathy (DR): This segment has a high demand for AI eye screening software because of diabetes and the resulting DR. Hence, with the use of AI, DR can be screened and closely watched in order to prevent vision loss.
  • Age-Related Macular Degeneration (AMD): The global population is ageing, and this is creating a higher rate of occurrence of AMD, hence the need to employ the use of artificial intelligence for screening. It also highlights how AI can pick early symptoms of AMD in a way that will allow for early treatment.
  • Myopia: Myopia is less frequent than near sightedness but is also widely present and remains a relevant problem in terms of human eye health in some geographic areas. Screening through the use of artificial intelligence re-time checks on the degree of myopia and advises on the right course of action to take.

By Application

Based on Application the market can be categorized into Medical Institutions & Great Health Scene

  • Medical Institutions: Hospitals, clinics, and eyecare centres are the main users of the AI eye screening software. Such institutions receive the added advantages of increased efficiency, early disease diagnoses, and quality patient care.
  • Great Health Scene: Current this segment includes methods and applications of telemedicine, mobile applications, and other digital solutions in the field of health and medicine. To enhance the accessibility of eye care and make it convenient to access, AI eye screening software can fit well into these platforms.

MARKET DYNAMICS

Market Dynamics Include Driving and Restraining Factors, Opportunities and Challenges Stating the Market Conditions.

Driving Factors

Rising Prevalence of Eye Diseases to Expand the Market

One of the key driving factors of Artificial Intelligence Eye Screening Software Market growth is the Rising Prevalence of Eye Diseases. The factors like growth of the geriatric population, rise in the number of cataracts, and other diseases like glaucoma, diabetic retinopathy, and age-related macular degeneration are stimulating the market. The use of screening solutions through artificial intelligence reduces the chances of early detection of disease, hence enhancing the health of patients.

Technological Advancements to Advance the Market

Additional enhancements to the AI as of deep learning algorithms and image analysis are helping to make repeated and better eye screening. In this case, the following technological advancements are exerting pressure to apply artificial intelligence solutions in the healthcare industry:

Restraining Factor

High Initial Cost to Propel the Market Growth

The primary barrier to adoption for this AI Eye Screening Software Market share includes the high initial cost of deployment. An additional benefit of the utilisation of AI in the healthcare sector is that early disease detection and possible prevention equals long-term expenditure reduction; however, capital-intensive expenses incurred in the acquisition of hardware, software, and training hinder smaller healthcare service providers. Furthermore, the issues of data privacy and security are also other challenges that may slow the growth of the market.

Opportunity

Early Diagnosis to Create Opportunity in this Market

A key opportunity factor that promotes the application of the AI eye screening software market is the increased focus on early diagnosis and checking of the health status. With health care moving more into a prevention model, AI-based screening is a use case of value in the early identification of eye diseases. It is for this very reason that this trend is anticipated to fuel growth in the market and bring on the wide-scale usage of AI solutions.

Challenge

Regulatory Environment to Pose Potential Challenge for this Market

A key threatening factor for the AI eye screening software market is the regulatory environment. Making the medical products with AI accurate, reliable, and safe can be a big challenge, and this process may take some time. Barriers such as regulatory approvals such as FDA in the United States may be quite a challenge to market entry and growth.

ARTIFICIAL INTELLIGENCE EYE SCREENING SOFTWARE MARKET REGIONAL INSIGHTS

  • North America

North America is the global leader in healthcare technology, and this region is also responsible for paving the way to introduce, adapt, and integrate AI eye screening software. End user organisations located in the area are availing services of big names in the technology industry and research facilities to evolve optimal solutions. With the United States Artificial Intelligence Eye Screening Software Market as the global leader in healthcare technology and innovation, this market has a large presence of major technology companies and research institutions that remain involved in creating and marketing AI-based eye screening solutions. 

  • Europe

The continent of Europe is keen on healthcare research as well as development; many countries within the region invest in artificial intelligence technologies. The region has stringent regulatory measures pertaining to data privacy and protection, which create some level of volatility in the market relating to data exchange and policies.

  • Asia

The Asia-Pacific region, as one of the largest populated continents with increasing middle-income people, constituted many market potentialities for the AI eye screening software. Growing incidence rates of eye ailments and the growing requirements for accessible health care products are factors contributing to market growth.

KEY INDUSTRY PLAYERS

Key Players Transforming the Artificial Intelligence Eye Screening Software Market through Research and Development

Research development strategies by key industrial players, their product portfolios, and market strategies define the global AI eye screening software market. They fund ongoing projects requiring the invention of better algorithms, enhancing image analysis, as well as incorporating AI into existing healthcare structures. They can also affect AI eye screening solutions adoption by owning some market infrastructure or having a positive brand image. 

List of Top Artificial Intelligence Eye Screening Software Companies

  • Airdoc Technology (China)
  • Digital Diagnostics (U.S.)
  • Eyenuk (U.S.)
  • RetinaLyze System (Denmark)
  • Optomed (Finland)

INDUSTRIAL DEVELOPMENT

2023: Google has introduced some new innovations in AI for eye screening software tool. Their research study has established deep learning models good to pick early features of diabetic retinopathy from the retinal images with very high sensitivity and specificity. These techniques have possibilities into early detection and treatment of this eye disease to enhance the prognosis of the patients.

REPORT COVERAGE

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global Artificial Intelligence Eye Screening Software Market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.

Artificial Intelligence Eye Screening Software Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 0.22 Billion in 2024

Market Size Value By

US$ 54.87 Billion by 2033

Growth Rate

CAGR of 84% from 2024 to 2033

Forecast Period

2024-2032

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

Types & Application

FAQs